Evidence map›Paper›PMID 35062710›Full record

ArticleVaccines2021

Biophysical Characterization of Viral and Lipid-Based Vectors for Vaccines and Therapeutics with Light Scattering and Calorimetric Techniques.

Natalia Markova, Stefan Cairns, Hanna Jankevics-Jones, Michael Kaszuba, Fanny Caputo, Jérémie Parot

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Impact of ionizable lipid source on quality and stability of siRNA-loaded lipid nanoparticles.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Multiparametric functional characterization of individual lipid nanoparticles using surface-sensitive light-scattering microscopy.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Construction of aMolecular therapy. Nucleic acids · 2024
    Article
  16. A Physiochemical,ACS applied bio materials · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia MarkovaMalvern Panalytical Ltd., Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ, UK.
Stefan CairnsMalvern Panalytical Ltd., Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ, UK.
Hanna Jankevics-JonesMalvern Panalytical Ltd., Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ, UK.
Michael KaszubaMalvern Panalytical Ltd., Enigma Business Park, Grovewood Road, Malvern, Worcestershire WR14 1XZ, UK.
Fanny CaputoDepartment of Biotechnology and Nanomedicine, SINTEF Industry, 7465 Trondheim, Norway.
Jérémie ParotDepartment of Biotechnology and Nanomedicine, SINTEF Industry, 7465 Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel vaccine platforms for delivery of nucleic acids based on viral and non-viral vectors, such as recombinant adeno associated viruses (rAAV) and lipid-based nanoparticles (LNPs), hold great promise. However, they pose significant manufacturing and analytical challenges due to their intrinsic structural complexity. During product development and process control, their design, characterization, and quality control require the combination of fit-for-purpose complementary analytical tools. Moreover, an in-depth methodological expertise and holistic approach to data analysis are required for robust measurements and to enable an adequate interpretation of experimental findings. Here the combination of complementary label-free biophysical techniques, including dynamic light scattering (DLS), multiangle-DLS (MADLS), Electrophoretic Light Scattering (ELS), nanoparticle tracking analysis (NTA), multiple detection SEC and differential scanning calorimetry (DSC), have been successfully used for the characterization of physical and chemical attributes of rAAV and LNPs encapsulating mRNA. Methods' performance, applicability, dynamic range of detection and method optimization are discussed for the measurements of multiple critical physical-chemical quality attributes, including particle size distribution, aggregation propensity, polydispersity, particle concentration, particle structural properties and nucleic acid payload.

Indexed as

adeno associated virusesmRNA-LNPsmRNA-LNP stabilityparticle concentrationparticle size distributionparticle structurepolydispersityquality controlrAAV stabilityvaccines

Identifiers

PMID35062710
PMCPMC8780473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.